Andrew H. Galligan, Chief Financial Officer at NEVRO CORP (NVRO), sold 37,044 shares at $104.74 ($3.8M) on 2019-11-11, disclosed to the SEC on 2019-11-13.
Seasonal sale ($3.8M) by Chief Financial Officer — this insider has traded NVRO in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.31 | 7,002 | $723K | 18.8% |
| 2 | $103.31 | 7,002 | $723K | 18.8% |
| 3 | $103.85 | 10,345 | $1.1M | 28.0% |
| 4 | $103.85 | 10,345 | $1.1M | 28.0% |
| 5 | $104.74 | 1,175 | $123K | 3.2% |
| 6 | $104.74 | 1,175 |
| $123K |
| 3.2% |
| Total | $103.70 avg | 37,044 | $3.8M | 100% |
| Filing → |
| NVRO | SELL | 2020-01-10 | $4.3M | — | Filing → |
| NVRO | SELL | 2020-01-08 | $334K | — | Filing → |
| NVRO | SELL | 2019-11-26 | $1.3M | — | Filing → |